EHA2021 CML Education Session
CML Education Session and others
- CML Education Session -
Stem cells targeting in CML. On demand from 11 June 2021 09:00 AM CET.
Chair: O Hantschel (Germany)
- CML Biology. M Deininger (United States)
- Immune cell contexture and response. S Mustjoki (Finland)
- Treatment-free remission in CML. FX Mahon (France)
Live Q&A Panel Discussion. 16 June 2021 4:00 PM - 4:45 PM CET, Virtual room 1.
- EHA2021 Satellite Simposia -
Unmet needs in the later line treatment of CML: understanding patient and physician perspectives. Novartis sponsored. 10 June 2021 1:30 PM - 3:00 PM CET. Virtual room 1.
Chair: F. Lang (Germany)
- Welcome and Introduction Segment
- Patient and physician perspectives: Are we meeting the goals of treatment in later lines of therapy for CML? L. Machado (Canada) Co-Speaker: F. Lang
- Prioritizing the unmet needs: where do we go from here? F. Lang (Germany)
- Exploring novel agents in later line CML. J-V Garcia-Gutierrez (Spain)
- Live Q&A. F. Lang (Germany). Co-Speaker: L. Machado, J-V Garcia-Gutierrez.
- Plenary Sessions -
Plenary Session II: 12 June 2021 3:15 PM - 3:45 PM CET
p202-3 Physiopathology of coagulopathy in hematological malignancies and in COVID-19. Dr. Marcel Levi, The Netherlands.
- Joint Symposia -
EHA-CSH Joint Symposium: COVID-19 in hematology 12 June 2021 10:00 AM - 11:00 AM CET. Virtual room 1.
Chairs: J Gribben (United Kingdom) & D Wu (China)
Abnormalities in thrombosis and hemostasis in patients with COVID-19. H Yu (China)